Skip to main content

Jessica Hagen and Anthony Vecchione

By Jessica Hagen and Anthony Vecchione | 02:36 pm | June 24, 2025
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
By Jessica Hagen and Anthony Vecchione | 07:11 pm | March 06, 2025
Chad Dodd, vice president of product management at athenahealth, sat down with MobiHealthNews to discuss Ambient Notes and how the company's AI-enabled products have evolved.   
By Jessica Hagen and Anthony Vecchione | 05:37 pm | February 13, 2025
The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.
By Jessica Hagen and Anthony Vecchione | 02:30 pm | January 03, 2025
Integral to the certification is ModMed's AI-powered ambient listening technology, ModMed Scribe, which employs AI in its EHR.  
By Jessica Hagen and Anthony Vecchione | 10:00 am | January 02, 2025
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.
By Jessica Hagen and Anthony Vecchione | 03:29 pm | December 23, 2024
Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.
By Jessica Hagen and Anthony Vecchione | 12:54 pm | December 20, 2024
Digital health leaders comment on the year's significant events, including the shuttering of Walmart Health, the CrowdStrike outage, concerns about off-label advertising and more.
By Jessica Hagen and Anthony Vecchione | 01:49 pm | December 17, 2024
Industry leaders weigh in on notable topics that affected healthcare from data security to health system consolidation.